CFI
Live / Registered — Registered (as of 31 Jan 2023)
What this means for you
Registered since 31 Jan 2023. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 31 Jan 2029: the §8 declaration of use).
Record
- Serial number
- 90062017
- Registration number
- 6969539
- Mark type
- Word mark
- Filed
- 20 Jul 2020
- Published for opposition
- 28 Sept 2021
- Registered
- 31 Jan 2023
- Next maintenance filing
- §8 declaration of use, due by 31 Jan 2029 (grace period to 31 Jul 2029)
Goods and services
- Class 040 — Treatment of materials: Custom manufacturing of pharmaceutical agents including blood products and biological products
Owner
- Aphios Corporation, Woburn, MA, US
- Aphios Corporation, Woburn, MA, US
- Aphios Corporation, Woburn, MA, US
Prosecution history
- 31 Jan 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 31 Jan 2023 — REGISTERED-PRINCIPAL REGISTER
- 30 Dec 2022 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 29 Dec 2022 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 29 Dec 2022 — EXAMINER'S AMENDMENT ENTERED
- 29 Dec 2022 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 29 Dec 2022 — EXAMINERS AMENDMENT E-MAILED
- 29 Dec 2022 — SU-EXAMINER'S AMENDMENT WRITTEN
- 30 Jun 2022 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 30 Jun 2022 — NON-FINAL ACTION E-MAILED
- 30 Jun 2022 — SU - NON-FINAL ACTION - WRITTEN
- 25 May 2022 — STATEMENT OF USE PROCESSING COMPLETE
- 12 May 2022 — USE AMENDMENT FILED
- 25 May 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 12 May 2022 — TEAS STATEMENT OF USE RECEIVED